H
Hua Medicine
HKEX:2552
Hua Medicine
HKEX:2552
Price:
3.22
HKD
3.21%
Market Cap:
HK$3.4B
Income Statement
Earnings Waterfall
Hua Medicine
Hua Medicine
Income Statement
Hua Medicine
Hua Medicine
Currency: CNY
| Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
0
|
0
|
1
|
3
|
4
|
4
|
4
|
4
|
4
|
5
|
8
|
9
|
9
|
9
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
18
N/A
|
88
+400%
|
77
-13%
|
109
+42%
|
256
+135%
|
371
+45%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
(36)
|
(39)
|
(68)
|
(131)
|
(176)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
8
N/A
|
52
+573%
|
37
-28%
|
41
+10%
|
125
+204%
|
195
+56%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(360)
|
(601)
|
(448)
|
(385)
|
(354)
|
(343)
|
(317)
|
(265)
|
(238)
|
(246)
|
(261)
|
(310)
|
(382)
|
875
|
|
| Selling, General & Administrative |
(100)
|
(175)
|
(147)
|
(138)
|
(140)
|
(138)
|
(135)
|
(140)
|
(145)
|
(184)
|
(204)
|
(219)
|
(270)
|
(265)
|
|
| Research & Development |
(269)
|
(436)
|
(322)
|
(268)
|
(221)
|
(207)
|
(187)
|
(161)
|
(130)
|
(128)
|
(172)
|
(220)
|
(215)
|
(161)
|
|
| Other Operating Expenses |
9
|
9
|
21
|
21
|
7
|
2
|
5
|
36
|
37
|
66
|
114
|
129
|
103
|
1 301
|
|
| Operating Income |
(360)
N/A
|
(601)
-67%
|
(448)
+25%
|
(385)
+14%
|
(354)
+8%
|
(343)
+3%
|
(317)
+8%
|
(265)
+16%
|
(230)
+13%
|
(194)
+16%
|
(224)
-15%
|
(269)
-20%
|
(257)
+5%
|
1 069
N/A
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
(3 201)
|
(3 196)
|
23
|
22
|
(42)
|
(45)
|
(9)
|
0
|
27
|
5
|
13
|
6
|
7
|
7
|
|
| Non-Reccuring Items |
(39)
|
(39)
|
0
|
0
|
3
|
3
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(4)
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(3 604)
N/A
|
(3 839)
-7%
|
(425)
+89%
|
(363)
+15%
|
(393)
-8%
|
(385)
+2%
|
(326)
+15%
|
(265)
+19%
|
(204)
+23%
|
(189)
+7%
|
(211)
-12%
|
(263)
-25%
|
(250)
+5%
|
1 076
N/A
|
|
| Net Income | |||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(3 604)
|
(3 839)
|
(425)
|
(363)
|
(393)
|
(385)
|
(326)
|
(265)
|
(204)
|
(189)
|
(211)
|
(263)
|
(250)
|
1 076
|
|
| Income to Minority Interest |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(3 603)
N/A
|
(3 838)
-7%
|
(425)
+89%
|
(363)
+15%
|
(393)
-8%
|
(385)
+2%
|
(326)
+15%
|
(265)
+19%
|
(204)
+23%
|
(189)
+7%
|
(211)
-12%
|
(263)
-25%
|
(250)
+5%
|
1 076
N/A
|
|
| EPS (Diluted) |
-10.07
N/A
|
-4.08
+59%
|
-0.45
+89%
|
-0.38
+16%
|
-0.41
-8%
|
-0.4
+2%
|
-0.34
+15%
|
-0.28
+18%
|
-0.21
+25%
|
-0.19
+10%
|
-0.22
-16%
|
-0.27
-23%
|
-0.25
+7%
|
1.08
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
